rawfin.tv
C4 Therapeutics Files Form 8-K on September 25
RegulationstocksAI Generated

C4 Therapeutics Files Form 8-K on September 25

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

C4 Therapeutics Inc. submitted a Form 8-K to the Securities and Exchange Commission on September 25, 2026. This regulatory filing typically reports significant events that shareholders should know.

C4 TherapeuticsSEC FilingForm 8-KBiotechRegulation

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks